Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPIRONDINE trial of desogestrel (Cerazette) in congenital central hypoventilation syndrome
2011-000989-35Phase 2
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of desogestrel in congenital central hypoventilation syndrome (CCHS), sponsored by Assistance publique - Hôpitaux de Paris.
02
Drugs
desogestrel
03
Conditions
congenital central hypoventilation syndrome (CCHS)
Beyond the preview
Go deeper on 2011-000989-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000989-35.